Literature DB >> 7708659

Platelet von Willebrand factor in inherited and acquired bleeding disorders.

P M Mannucci1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7708659      PMCID： PMC42231          DOI： 10.1073/pnas.92.7.2428

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  53 in total

1.  Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.

Authors:  E J Bowie; L A Solberg; D N Fass; C M Johnson; G J Knutson; M L Stewart; L J Zoecklein
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

2.  Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease.

Authors:  H R Gralnick; M E Rick; L P McKeown; S B Williams; R I Parker; P Maisonneuve; C Jenneau; Y Sultan
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

3.  Commentary: a new classification for von Willebrand disease.

Authors:  J E Sadler; H R Gralnick
Journal:  Blood       Date:  1994-08-01       Impact factor: 22.113

4.  Plasma and platelet von Willebrand factor defects in uremia.

Authors:  H R Gralnick; L P McKeown; S B Williams; B C Shafer; L Pierce
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

5.  Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.

Authors:  P M Mannucci; R Lombardi; R Bader; L Vianello; A B Federici; S Solinas; M G Mazzucconi; G Mariani
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

6.  Purification and characterization of human platelet von Willebrand factor.

Authors:  S B Williams; L P McKeown; H Krutzsch; K Hansmann; H R Gralnick
Journal:  Br J Haematol       Date:  1994-11       Impact factor: 6.998

7.  Platelet von Willebrand factor: comparison with plasma von Willebrand factor.

Authors:  H R Gralnick; S B Williams; L P McKeown; D M Krizek; B C Shafer; M E Rick
Journal:  Thromb Res       Date:  1985-06-15       Impact factor: 3.944

8.  Studies on the prolonged bleeding time in von Willebrand's disease.

Authors:  R K Smiley; P Tittley; G Rock
Journal:  Thromb Res       Date:  1989-03-01       Impact factor: 3.944

9.  Biosynthesis of von Willebrand protein by human megakaryocytes.

Authors:  L A Sporn; S I Chavin; V J Marder; D D Wagner
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.

Authors:  K S Sakariassen; P F Nievelstein; B S Coller; J J Sixma
Journal:  Br J Haematol       Date:  1986-08       Impact factor: 6.998
View more
  11 in total

1.  Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Authors:  Michelle Lavin; Sonia Aguila; Sonja Schneppenheim; Niall Dalton; Kenneth L Jones; Jamie M O'Sullivan; Niamh M O'Connell; Kevin Ryan; Barry White; Mary Byrne; Marie Rafferty; Mairead M Doyle; Margaret Nolan; Roger J S Preston; Ulrich Budde; Paula James; Jorge Di Paola; James S O'Donnell
Journal:  Blood       Date:  2017-09-15       Impact factor: 22.113

Review 2.  Alloantibodies in von Willebrand disease.

Authors:  Paula D James; David Lillicrap; Pier M Mannucci
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

3.  Production of recombinant proteins in Chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin.

Authors:  T A Ayoubi; S M Meulemans; A J Roebroek; W J Van de Ven
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

4.  A revised model of platelet aggregation.

Authors:  S Kulkarni; S M Dopheide; C L Yap; C Ravanat; M Freund; P Mangin; K A Heel; A Street; I S Harper; F Lanza; S P Jackson
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 5.  New treatment approaches to von Willebrand disease.

Authors:  Michelle Lavin; James S O'Donnell
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

6.  Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.

Authors:  M L Bowman; F G Pluthero; A Tuttle; L Casey; L Li; H Christensen; K S Robinson; D Lillicrap; W H A Kahr; P James
Journal:  J Thromb Haemost       Date:  2017-06-06       Impact factor: 5.824

7.  Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Authors:  Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jorgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

8.  Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.

Authors:  Nirav Dhanesha; Prem Prakash; Prakash Doddapattar; Ira Khanna; Molly J Pollpeter; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

Review 9.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

10.  Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.

Authors:  Prakash Doddapattar; Nirav Dhanesha; Mehul R Chorawala; Chandler Tinsman; Manish Jain; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-18       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.